VitaNova Life Sciences (VNOV) Share-based Compensation (2024 - 2026)
VitaNova Life Sciences' (VNOV) quarterly Share-based Compensation came in at $179400.0 in Q2 2026, up 35780.0% on a QoQ basis from $500.0 in Q1 2025.
Analysis
VitaNova Life Sciences (VNOV) Share-based Compensation (2024 - 2026) Analysis & Trends
VitaNova Life Sciences has disclosed Share-based Compensation across 3 years of filings, most recently posting $179400.0 for Q2 2026.
- Share-based Compensation for Q2 2026 came in at $179400.0, changed N/A year-over-year; the trailing twelve-month figure through Apr 2026 was $179400.0 (up 8870.0% YoY), and the FY2026 annual result was $179400.0, up 8870.0% from the prior year.
- Share-based Compensation for Q2 2026 stood at $179400.0, up from $500.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $179400.0 in Q2 2026 and bottomed at $500.0 in Q1 2025.
- Average Share-based Compensation over 3 years is $36480.0, with a median of $750.0 recorded in 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn | 462.14 Mn |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn | 23.00 Mn |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn | 40.99 Mn |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn | 21.00 Mn |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn | 9.77 Mn |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn | 26.36 Mn |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn | 3.46 Mn |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn | 11.44 Mn |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn | 24.91 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 179,400.00 |
| Jan 31, 2025 | 500.00 |
| Oct 31, 2024 | 750.00 |
| Jul 31, 2024 | 750.00 |
| Apr 30, 2024 | 1,000.00 |